114 related articles for article (PubMed ID: 9990483)
1. Cyclin D1 gene amplification and p16 gene deletion in patients with esophageal carcinosarcoma.
Suzuki H; Fujioka Y; Nagashima K
Diagn Mol Pathol; 1998 Oct; 7(5):253-9. PubMed ID: 9990483
[TBL] [Abstract][Full Text] [Related]
2. Cyclin D1 gene amplification in esophageal carcinosarcoma shown by differential polymerase chain reaction.
Suzuki H; Moriya J; Nakahata A; Fujioka Y; Inoue K; Nagashima K
Hum Pathol; 1998 Jul; 29(7):662-7. PubMed ID: 9670821
[TBL] [Abstract][Full Text] [Related]
3. Carcinosarcoma of the tongue with cyclin D1 gene amplification.
Suzuki H; Yamashiro K; Yoshida C; Fujioka Y
Arch Pathol Lab Med; 2001 Mar; 125(3):433-6. PubMed ID: 11231499
[TBL] [Abstract][Full Text] [Related]
4. Deletion of the p16 gene and microsatellite instability in carcinoma arising in pleomorphic adenoma of the parotid gland.
Suzuki H; Fujioka Y
Diagn Mol Pathol; 1998 Aug; 7(4):224-31. PubMed ID: 9917133
[TBL] [Abstract][Full Text] [Related]
5. Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors.
Namazie A; Alavi S; Olopade OI; Pauletti G; Aghamohammadi N; Aghamohammadi M; Gornbein JA; Calcaterra TC; Slamon DJ; Wang MB; Srivatsan ES
Laryngoscope; 2002 Mar; 112(3):472-81. PubMed ID: 12148857
[TBL] [Abstract][Full Text] [Related]
6. [Loss of CDKN2 gene and amplification of cyclin D1 gene in human esophageal cancer].
Zheng J; Hou P; Zhou C
Zhonghua Zhong Liu Za Zhi; 1996 Nov; 18(6):408-11. PubMed ID: 9387288
[TBL] [Abstract][Full Text] [Related]
7. Highly frequent homozygous deletion of the p16 gene in esophageal cancer cell lines.
Igaki H; Sasaki H; Kishi T; Sakamoto H; Tachimori Y; Kato H; Watanabe H; Sugimura T; Terada M
Biochem Biophys Res Commun; 1994 Sep; 203(2):1090-5. PubMed ID: 8093026
[TBL] [Abstract][Full Text] [Related]
8. Array-based comparative genomic hybridization of circulating esophageal tumor cells.
Kim DH; Muto M; Kuwahara Y; Nakanishi Y; Watanabe H; Aoyagi K; Ogawa K; Yoshida T; Sasaki H
Oncol Rep; 2006 Nov; 16(5):1053-9. PubMed ID: 17016592
[TBL] [Abstract][Full Text] [Related]
9. Polymorphism of p16 INK4A and cyclin D1 in adenocarcinomas of the upper gastrointestinal tract.
Geddert H; Kiel S; Zotz RB; Zhang J; Willers R; Gabbert HE; Sarbia M
J Cancer Res Clin Oncol; 2005 Dec; 131(12):803-8. PubMed ID: 16163549
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of the p16INK4, p15INK4B genes abnormality and the amplification of cyclin D1 gene in esophageal cancer].
Takamura H; Fushida S; Hashimoto T; Yagi M; Miyazaki I
Nihon Rinsho; 1996 Apr; 54(4):1043-8. PubMed ID: 8920671
[TBL] [Abstract][Full Text] [Related]
11. Expression of receptor tyrosine kinases in esophageal carcinosarcoma.
Sano A; Sakurai S; Kato H; Suzuki S; Yokobori T; Sakai M; Tanaka N; Inose T; Sohda M; Nakajima M; Fukai Y; Miyazaki T; Ojima H; Hosoya Y; Enomoto T; Kanda T; Ajioka Y; Kuwano H
Oncol Rep; 2013 Jun; 29(6):2119-26. PubMed ID: 23546020
[TBL] [Abstract][Full Text] [Related]
12. Cell cycle-related gene abnormalities and product expression in esophageal carcinoma.
Roncalli M; Bosari S; Marchetti A; Buttitta F; Bossi P; Graziani D; Peracchia A; Bonavina L; Viale G; Coggi G
Lab Invest; 1998 Sep; 78(9):1049-57. PubMed ID: 9759649
[TBL] [Abstract][Full Text] [Related]
13. Differential polymerase chain reaction assay of cyclin D1 gene amplification in esophageal carcinoma.
Gramlich TL; Fritsch CR; Maurer D; Eberle M; Gansler TS
Diagn Mol Pathol; 1994 Dec; 3(4):255-9. PubMed ID: 7866635
[TBL] [Abstract][Full Text] [Related]
14. Cyclin D1 amplification is independent of p16 inactivation in head and neck squamous cell carcinoma.
Okami K; Reed AL; Cairns P; Koch WM; Westra WH; Wehage S; Jen J; Sidransky D
Oncogene; 1999 Jun; 18(23):3541-5. PubMed ID: 10376532
[TBL] [Abstract][Full Text] [Related]
15. Altered p16/MTS1/CDKN2 and cyclin D1/PRAD-1 gene expression is associated with the prognosis of squamous cell carcinoma of the esophagus.
Takeuchi H; Ozawa S; Ando N; Shih CH; Koyanagi K; Ueda M; Kitajima M
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2229-36. PubMed ID: 9815619
[TBL] [Abstract][Full Text] [Related]
16. [Deletion of MTS1/p16 gene in human esophageal carcinoma].
Jin S; Peng Q; Lu S
Zhonghua Zhong Liu Za Zhi; 1998 Jan; 20(1):9-11. PubMed ID: 10921045
[TBL] [Abstract][Full Text] [Related]
17. Hemizygous or homozygous deletion of the chromosomal region containing the p16INK4a gene is associated with amplification of the EGF receptor gene in glioblastomas.
Hegi ME; zur Hausen A; Rüedi D; Malin G; Kleihues P
Int J Cancer; 1997 Sep; 73(1):57-63. PubMed ID: 9334810
[TBL] [Abstract][Full Text] [Related]
18. Amplification and expression of the cyclin D1 gene in anal and esophageal squamous cell carcinomas.
Sheyn I; Noffsinger AE; Heffelfinger S; Davis B; Miller MA; Fenoglio-Preiser CM
Hum Pathol; 1997 Mar; 28(3):270-6. PubMed ID: 9042789
[TBL] [Abstract][Full Text] [Related]
19. Molecular and clinicopathological analyses of esophageal carcinosarcoma with special reference to morphological change.
Tsuyama S; Saito T; Akazawa Y; Yanai Y; Yatagai N; Akaike K; Hayashi T; Suehara Y; Takahashi F; Takamochi K; Hashimoto T; Kajiyama Y; Tsurumaru M; Fukunaga T; Yao T
Virchows Arch; 2019 Oct; 475(4):415-424. PubMed ID: 31444625
[TBL] [Abstract][Full Text] [Related]
20. Fluorescence in situ hybridization for detecting genomic alterations of cyclin D1 and p16 in oral squamous cell carcinomas.
Uzawa N; Sonoda I; Myo K; Takahashi K; Miyamoto R; Amagasa T
Cancer; 2007 Nov; 110(10):2230-9. PubMed ID: 17893905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
